Evidence map›Paper›PMID 37590165›Full record

ArticleJournal of the American Society for Mass Spectrometry2023

All-in-One Pseudo-MS

Nicholas I Brodie, Vladimir Sarpe, D Alex Crowder, David Schriemer

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nicholas I BrodieDepartment of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada T2N-4N1.
Vladimir SarpeDepartment of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada T2N-4N1.
D Alex CrowderDepartment of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada T2N-4N1.
David SchriemerDepartment of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada T2N-4N1.ORCID 0000-0002-5202-1618
University of Calgary · CA

Funding

Transcription-Coupled & Replication-Associated Excision RepairP01CA092584 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI WALTER J. CHAZIN · 2001 to 2026
$89.6M
NCI NIH HHS P01 CA092584
6 · The paper itself

Abstract

Crosslinking mass spectrometry (XL-MS) supports structure analysis of individual proteins and highly complex whole-cell interactomes. The identification of crosslinked peptides from enzymatic digests remains challenging, especially at the cell level. Empirical methods that use gas-phase cleavable crosslinkers can simplify the identification process by enabling an MS

Indexed as

PeptidesSerum Albumin, BovineCross-Linking ReagentsMass SpectrometryProtein Structure, SecondaryCross-Linking ReagentsPeptidesSerum Albumin, Bovine

Identifiers

PMID37590165
PMCPMC11250984
OpenAlexW4385945346

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.